These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6111027)

  • 1. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
    Chiu S; Mishra RK
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):45-50. PubMed ID: 6111027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between narcotic antagonist (naloxone) and lysergic acid diethylamide (LSD) in the rat.
    Fertziger AP; Fischer R
    Psychopharmacology (Berl); 1977 Nov; 54(3):313-4. PubMed ID: 413151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings.
    Chiu S; Paulose CS; Mishra RK
    Peptides; 1981; 2(1):105-11. PubMed ID: 6113579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Mishra RK
    Eur J Pharmacol; 1979 Jan; 53(2):119-25. PubMed ID: 32058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
    Quock RM; Lucas TS; Hartl TJ
    Pharmacol Biochem Behav; 1983 Jul; 19(1):49-52. PubMed ID: 6137836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholingeric drugs on methadone-induced catalepsy and stereotypies in rats treated chronically with methadone.
    Ahtee L
    Eur J Pharmacol; 1976 Oct; 39(2):203-13. PubMed ID: 987911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
    Ott MC; Mishra RK; Johnson RL
    Brain Res; 1996 Oct; 737(1-2):287-91. PubMed ID: 8930377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.
    Kaakkola S; Ahtee L
    Psychopharmacology (Berl); 1977 Mar; 52(1):7-15. PubMed ID: 403561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats.
    Costain WJ; Buckley AT; Evans MC; Mishra RK; Johnson RL
    Peptides; 1999; 20(6):761-7. PubMed ID: 10477133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.
    Persson SA
    Eur J Pharmacol; 1977 May; 43(1):73-83. PubMed ID: 16756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibition of post-ganglionic motor transmission in the mammalian vas deferens by D-lysergic acid diethylamide.
    Ambache N; Dunk LP; Verney J; Zar MA
    J Physiol; 1973 Jun; 231(2):251-70. PubMed ID: 4352765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of dopamine agonists and an opiate antagonist on agaricus-induced catalepsy, as tested by a new method.
    Sukul NC; Klemm WR
    Arch Int Pharmacodyn Ther; 1988; 295():40-51. PubMed ID: 2907723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of dermorphin-induced catalepsy with naloxone, TRH-analog CG3703 and the benzodiazepine antagonist, Ro 15-1788.
    Paakkari P; Feuerstein G
    Neuropharmacology; 1988 Oct; 27(10):1007-12. PubMed ID: 2907115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prolyl-leucyl-glycinamide and alpha-melanocyte-stimulating hormone on levorphanol-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Life Sci; 1984 Jun; 34(26):2559-66. PubMed ID: 6146083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effects of prolyl-leucyl-glycinamide on morphine-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Eur J Pharmacol; 1984 Jun; 102(1):13-22. PubMed ID: 6148243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolyl-leucyl-glycinamide (PLG): inhibition of offensive aggression in mice.
    Kavaliers M; Hirst M
    Life Sci; 1986 Nov; 39(19):1729-35. PubMed ID: 2877382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.